Pediatric Cancer
Strategy Trims Antibiotic Use in Pediatric Cancer Patients
Pediatric oncologists at Monroe Carell Jr. Children's Hospital at Vanderbilt were able to reduce by 70 percent antibiotic use in pediatric oncology patients with fever but who were not neutropenic.

A long-term commitment to curbing excess antibiotic use in children with cancer led to development of the model for the practice.

Recently, the team examined their model's performance in predicting these infections in autologous and allogeneic stem cell transplant (SCT) recipients.

Their findings were published in Cancer.

Read the Full Story
Innovation in Your Inbox from Vanderbilt University Medical Center

Get the latest breakthroughs in medical science and patient care with Discoveries in Medicine, VUMC's digital platform for physicians.

Subscribe Now
Latest Stories

Large study results argue against time-prescribed antibiotics for febrile children with cancer.

Study exposes low utility of sinus CT, the most common test given to febrile neutropenic pediatric patients with cancer.

 

Researchers study the impact of SAMD9 overexpression and mechanisms leading to bone marrow failure.

Best Children's Hospitals 2024-2025

U.S. News and World Report has ranked Monroe Carell Jr. Children's Hospital at Vanderbilt #1 in Tennessee and the entire Southeast.